The British Medical Supervisory Authority said on Saturday that of the 30 people who got blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
“Unfortunately, of the 30 reports up to and including 24 March, seven have died,” the Swedish Medicines Agency (MHRA) said in a statement to AFP.
In the announcement of the thirty cases of blood clots on Friday, the MHRA said that “the benefits of the vaccines against Covid-19 continue to outweigh all risks” and urges the public to continue taking the vaccine.
As of March 24, 22 reports of cerebral venous sinus thrombosis (CVST) and eight other low-platelet thrombotic events were recorded.
“The risk of having this specific type of blood clot is very small,” the agency noted.
“The number and nature of suspected side effects reported so far are not uncommon compared to other types of routinely used vaccines,” the MHRA’s online statement said on April 2.
However, there were no such reports for the Pfizer / BioNTech vaccine.
The Netherlands on Friday became the latest in a series of European countries to stop vaccinations with AstraZeneca jab for people under the age of 60 for fear of links to rare blood clots.
The move came after five new cases in the Netherlands that affected women between the ages of 25 and 65, one of whom died.
Germany had made a similar decision earlier this week.
The European Medicines Agency (EMA), which has also previously declared the AstraZeneca vaccine safe, as well as the World Health Organization, are expected to issue updated advice on the issue on 7 April.
The EMA said again on Wednesday that it believes the vaccine is safe and that experts have not found any specific risk factors such as age, gender or medical history.
The UK, where the vaccine was developed by Oxford University, has been one of the countries hardest hit by the coronavirus with almost 127,000 deaths.
( Jowharwith AFP)